title: Increased children's access to fluoride varnish treatment by involving medical care providers: effect of a Medicaid policy change.
abstract: BACKGROUND
  In 2004, the State of Wisconsin introduced a change to their Medicaid Policy allowing medical care providers to be reimbursed for fluoride varnish treatment provided to Medicaid enrolled children.
  
  
  OBJECTIVE
  To determine the extent by which a state-level policy change impacted access to fluoride varnish treatment (FVT) for Medicaid enrolled children.
  
  
  METHODS
  The Electronic Data Systems of Medicaid Evaluation and Decision Support database for Wisconsin from 2002 to 2006.
  
  
  METHODS
  We analyzed Wisconsin Medicaid claims for FVT for children between the ages of 1 and 6 years, comparing rates in the prepolicy period (2002-2003) to the period (2004-2006) following the policy change.
  
  
  RESULTS
  Medicaid claims for FVT in 2002-2003 totaled 3,631. Following the policy change, claims for FVT increased to 28,303, with 38.0 percent submitted by medical care providers. FVT rates increased for children of both sexes and all ages, rising from 1.4 per 1,000 person-years of enrollment in 2002-2003 to 6.6 per 1,000 person-years in 2004-2006. Overall, 48.6 percent of the increase in FVT was attributable to medical care providers. The largest increase was seen in children 1-2 years of age, among whom medical care providers were responsible for 83.5 percent of the increase.
  
  
  CONCLUSIONS
  A state-level Medicaid policy change was followed by both a significant involvement of medical care providers and an overall increase in FVT. Children between the ages of 1 and 2 years appear to benefit the most from the involvement of medical care providers.
authors.affiliation: Department of Clinical Services, Marquette University School of Dentistry, Milwaukee, WI 53201-1881, USA. christopher.okunseri@marquette
authors.forename: Christopher
authors.initials: C
authors.lastname: Okunseri
authors.forename: Aniko
authors.initials: A
authors.lastname: Szabo
authors.forename: Scott
authors.initials: S
authors.lastname: Jackson
authors.forename: Nicholas M
authors.initials: NM
authors.lastname: Pajewski
authors.forename: Raul I
authors.initials: RI
authors.lastname: Garcia
mesh_terms: D002327:Cariostatic Agents / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D005260:Female; D005460:Fluorides, Topical / Q000627:therapeutic use*; D006282:Health Personnel / Q000706:statistics & numerical data*; D006291:Health Policy; D006297:Health Services Accessibility / Q000458:organization & administration / Q000706:statistics & numerical data*; D006801:Humans; D007223:Infant; D008297:Male; D008484:Medicaid / Q000458:organization & administration / Q000706:statistics & numerical data*; D015397:Program Evaluation; D012189:Retrospective Studies; D014481:United States; D014922:Wisconsin
chemical_list: D002327:Cariostatic Agents; D005460:Fluorides, Topical